CHIMERIX INC

Profile

Company Names

CHIMERIX INC

Addresses

2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC 27713

2505 MERIDIAN PARKWAY, SUITE 340, DURHAM, NC 27713

2505 MERIDIAN PARKWAY, SUITE 340, DURHAM, NC 27713

Phone Numbers

(919) 806-1074
919.806.1074

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$96,030,021.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-07-26 
$34,900,000.00 
$34,900,000.00 
$0.00 
Equity 
2
2011-02-07 
$45,000,010.00 
$68,749,994.00 
$23,749,984.00 
Equity 
1
2009-07-24 
$16,130,011.00 
$16,145,011.00 
$15,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MERRICK 
 
ALMOND, PH.D. 
EXECUTIVE OFFICER
CHIMERIX INC
MICHAEL 
A. 
ALRUTZ 
EXECUTIVE OFFICER
CHIMERIX INC
MIKE 
 
ANDRIOLE 
EXECUTIVE OFFICER
CHIMERIX INC
FARAH 
 
CHAMPSI 
DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  ZELOS THERAPEUTICS INC   |  AEROVANCE INC   |  TREVENA INC   |  CHIMERIX INC   |  KITE PHARMA, INC.   |  ALLAKOS INC.
GRAHAM 
K. 
CROOKE, M.B.B.S. 
DIRECTOR
CHIMERIX INC
JAMES 
M. 
DALY 
DIRECTOR
CHIMERIX INC
MARTHA 
J. 
DEMSKI 
DIRECTOR
CHIMERIX INC
CATHERINE 
L. 
GILLISS 
DIRECTOR
CHIMERIX INC
EDWARD 
F. 
GREISSING, JR. 
DIRECTOR
CHIMERIX INC
HEATHER 
 
KNIGHT-TRENT 
EXECUTIVE OFFICER
CHIMERIX INC
RANDALL 
 
LANIER 
EXECUTIVE OFFICER
CHIMERIX INC
PATRICK 
 
MACHADO 
DIRECTOR
TURNSTONE BIOLOGICS CORP.   |  CHIMERIX INC   |  ADVERUM BIOTECHNOLOGIES, INC.   |  ALUMIS INC.   |  AVENZO THERAPEUTICS, INC.
ROBERT 
J. 
MEYER 
DIRECTOR
TRANSLATE BIO, INC.   |  CHIMERIX INC
FRED 
A. 
MIDDLETON 
DIRECTOR
ENDOCYTE INC   |  NOVOCELL, INC   |  CYLENE PHARMACEUTICALS, INC.   |  LINEAGEN INC   |  AXIKIN PHARMACEUTICALS INC   |  STEREOTAXIS, INC.   |  VIACYTE INC.   |  LINEAGEN, INC   |  CHIMERIX INC   |  MESA VERDE VENTURE PARTNERS IV, LP   |  THERAVIDA, INC.
KENNETH 
I. 
MOCH 
EXECUTIVE OFFICER, DIRECTOR
CHIMERIX INC   |  COGNITION THERAPEUTICS INC
ODIN 
 
NADERER 
EXECUTIVE OFFICER
CHIMERIX INC
W. 
GARRETT 
NICHOLS 
EXECUTIVE OFFICER
CHIMERIX INC
JAMES 
 
NIEDEL 
DIRECTOR
TIOGA PHARMACEUTICALS INC   |  INTARCIA THERAPEUTICS, INC   |  CHIMERIX INC   |  PEARL THERAPEUTICS INC
ROSEMARY 
 
O-MAHONY, PH.D. 
EXECUTIVE OFFICER
CHIMERIX INC
GWENDOLYN 
P. 
PAINTER, M.D., MPH 
EXECUTIVE OFFICER
CHIMERIX INC
GEORGE 
 
PAINTER, PH.D 
EXECUTIVE OFFICER, DIRECTOR
CHIMERIX INC
GEORGE 
 
PAINTER, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
CHIMERIX INC
ARTHUR 
M. 
PAPPAS 
DIRECTOR
PV IV CEO FUND, LP   |  CARDIODX INC   |  CHIMERIX INC   |  COLUCID PHARMACEUTICALS, INC.   |  PV V CEO FUND, LP   |  A. M. PAPPAS LIFE SCIENCE VENTURES V, LP
EDWARD 
E. 
PENHOET, PH.D. 
DIRECTOR
CHIMERIX INC   |  CYMABAY THERAPEUTICS, INC.
RONALD 
C. 
RENAUD, JR 
DIRECTOR
CHIMERIX INC
SETH 
A. 
RUDNICK, M.D. 
DIRECTOR
CHIMERIX INC   |  ARALEZ PHARMACEUTICALS INC.
MIKE 
 
SHERMAN 
EXECUTIVE OFFICER, DIRECTOR
ANULEX TECHNOLOGIES INC   |  ENDOCYTE INC   |  CALOSYN PHARMA, INC.   |  HUBBLE TELEMEDICAL INC.   |  S+H LLC   |  GENERAL FUSION INC.   |  CHIMERIX INC
ROY 
W. 
WARE 
EXECUTIVE OFFICER
CHIMERIX INC
TIMOTHY 
J. 
WOLLAEGER 
DIRECTOR
CHIMERIX INC   |  SOTERA WIRELESS, INC.   |  ASTERES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-07-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2019-07-26 
2011-02-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-07 
2009-08-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#